Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term extension study of AG-1749 in patients on chronic low-dose aspirin
jRCT2080220830Phase 3
- Sponsor
- Takeda
- Start
- Aug 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of lansoprazole in Peptic ulcer disease (PUD), sponsored by Takeda.
02
Drugs
lansoprazole
03
Conditions
Peptic ulcer disease (PUD)
Beyond the preview
Go deeper on jRCT2080220830.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220830.